RecruitingNCT06802874

Maternal-fetal Outcomes of Genital Blood Loss Beyond 18 Weeks of Pregnancy

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment

300 participants

Start Date

Nov 15, 2023

Study Type

OBSERVATIONAL

Conditions

blood loss

Summary

The primary objective is to assess in terms of frequency the adverse outcomes (premature birth, maternal-fetal haemorrhage, maternal fetal-neonatal death) of pregnancies of women attending the obstetric-gynaecological emergency department for genital bleeding beyond the 18th week of pregnancy.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with blood loss. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.